BioSenic S.A.
BIOS.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €1,567 | €1,879 | €33 | €9,154 |
| - Cash | €501 | €391 | €816 | €117 |
| + Debt | €20,776 | €27,727 | €26,794 | €28,161 |
| Enterprise Value | €21,842 | €29,215 | €26,011 | €37,198 |
| Revenue | €0 | €0 | €2,694 | €178 |
| % Growth | – | -100% | 1,413.5% | – |
| Gross Profit | €0 | -€93 | €2,694 | -€88 |
| % Margin | – | – | 100% | -49.4% |
| EBITDA | -€706 | -€5,526 | -€361 | -€2,996 |
| % Margin | – | – | -13.4% | -1,683.1% |
| Net Income | -€712 | -€5,263 | €495 | -€7,935 |
| % Margin | – | – | 18.4% | -4,457.9% |
| EPS Diluted | -0.001 | -0.016 | 0.25 | -0.053 |
| % Growth | 93.2% | -106.5% | 571.7% | – |
| Operating Cash Flow | – | -€1,387 | -€846 | -€1,540 |
| Capital Expenditures | – | €1,387 | €0 | €12 |
| Free Cash Flow | – | €0 | -€846 | -€1,528 |